SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Human & Experimental Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Institóris, L
Right arrow Articles by Petri, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Institóris, L
Right arrow Articles by Petri, I.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Extension of the protocol of OECD guideline 407 (28-day repeated dose oral toxicity test in the rat) to detect potential immunotoxicity of chemicals

L Institóris

Department of Public Health and WHO/IPCS Collaborating Centre, Albert Szent-Györgyi University Medical School, Szeged, Hungary

Olga Siroki

Department of Public Health and WHO/IPCS Collaborating Centre, Albert Szent-Györgyi University Medical School, Szeged, Hungary

I Dési

Department of Public Health and WHO/IPCS Collaborating Centre, Albert Szent-Györgyi University Medical School, Szeged, Hungary

J Lesznyák

Department of Pathology, Hollós József Hospital, Kecskemét, Hungary

P Serényi

Department of Pathology, Hollós József Hospital, Kecskemét, Hungary

Éva Szekeres

Department of Blood Transfusion, Albert Szent-Györgyi University Medical School, Szeged, Hungary

Ildikó Petri

Department of Blood Transfusion, Albert Szent-Györgyi University Medical School, Szeged, Hungary

To indicate the immunotoxic potential of chemicals the examinations prescribed by OECD Guideline 407 were extended by the following additional toxicological, haematological, histopathological, and immune function examinations: absolute and relative organ weight of spleen, thymus, popliteal lymph nodes, lung and brain; histopathology of thymus, mesenteric lymph nodes, popliteal lymph nodes, bone marrow (femur), Peyer's patches (ileum), lungs and colon; PFC assay (spleen), T cell proliferation and NK cell assay. Two well known immunosuppressants Azathioprine (AZA) and Cyclosporine A (CysA) were chosen as model compounds at a dose range which do not cause visible toxic signs on the animals during a 28 days treatment period. The results show that the applied experimental system is much more sensitive in detection of the immunotoxic potential of these two compounds in a low dose range than the examination required by OECD Guideline 407 are.

Key Words: Azathioprine • Cyclosporin A • immunotoxicity • rats

Human & Experimental Toxicology, Vol. 17, No. 4, 206-211 (1998)
DOI: 10.1177/096032719801700402


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Hum Exp ToxicolHome page
L Institoris, O Siroki, U Undeger, N Basaran, and I Desi
Immunotoxicological investigations on rats treated subacutely with dimethoate, As3+and Hg2+ in combination
Human and Experimental Toxicology, July 1, 2001; 20(7): 329 - 336.
[Abstract] [PDF]



Advertisement